abrdn Europe ex UK Income Equity Fund Standard Life AccumulationRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 9.0 | 17.2 | -0.6 | 13.3 | 4.1 | |
+/-Cat | -0.4 | 1.7 | 8.2 | -0.3 | 1.5 | |
+/-B’mrk | 1.1 | -0.1 | 6.9 | -1.7 | -0.4 | |
Category: Europe ex-UK Equity | ||||||
Category Benchmark: Morningstar DM Eur xUK TME ... |
Key Stats | ||
NAV 21/11/2024 | GBP 2.33 | |
Day Change | -0.64% | |
Morningstar Category™ | Europe ex-UK Equity | |
IA (formerly IMA) Sector | Europe Excluding UK | |
ISIN | GB00B87XTB15 | |
Fund Size (Mil) 21/11/2024 | GBP 294.15 | |
Share Class Size (Mil) 21/11/2024 | GBP 16.41 | |
Max Initial Charge | - | |
Ongoing Charge 19/08/2024 | 0.10% |
Investment Objective: abrdn Europe ex UK Income Equity Fund Standard Life Accumulation |
To generate income and some growth over the long term (5 years or more) by investing in European equities (company shares). The fund will invest at least 70% in equities and equity related securities of companies listed, incorporated, or domiciled in European countries, or companies that derive a significant proportion of their revenues or profits from European operations or have a significant proportion of their assets there. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Charles Luke 01/05/2024 | ||
Romney Fox 01/05/2024 | ||
Inception Date 05/04/2009 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
FTSE World Eur Ex UK TR GBP | Morningstar DM Eur xUK TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for abrdn Europe ex UK Income Equity Fund Standard Life Accumulation | 31/10/2024 |
|
|
Top 5 Holdings | Sector | % |
SAP SE | Technology | 5.53 |
Novartis AG Registered Shares | Healthcare | 4.73 |
Deutsche Telekom AG | Communication Services | 4.70 |
Novo Nordisk AS Class B | Healthcare | 4.17 |
Schneider Electric SE | Industrials | 4.10 |
Increase Decrease New since last portfolio | ||
abrdn Europe ex UK Income Equity Fund Standard Life Accumulation |